D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$365M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$307M |
| 3 |
Adobe
ADBE
|
+$250M |
| 4 |
NVIDIA
NVDA
|
+$242M |
| 5 |
Salesforce
CRM
|
+$240M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$520M |
| 2 |
ExxonMobil
XOM
|
+$372M |
| 3 |
Bank of America
BAC
|
+$271M |
| 4 |
Netflix
NFLX
|
+$172M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.14% |
| 2 | Financials | 9.37% |
| 3 | Healthcare | 7.49% |
| 4 | Consumer Discretionary | 6.79% |
| 5 | Communication Services | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Rapid7
RPD
$634M
| $25.9M | 0.03% |
604,647
+473,149
| +360% | +$29.2M |
|
627
Iovance Biotherapeutics
IOVA
$2.23B
| $25.8M | 0.03% |
2,695,220
+617,689
| +30% | +$7.12M |
|
628
Regeneron Pharmaceuticals
REGN
$68.8B
| $25.8M | 0.03% |
37,425
-26,903
| -42% | -$16.9M |
|
629
CALL
Union Pacific
UNP
$183B
| $25.8M | 0.03% |
132,200
-43,400
| -25% | -$9.6M |
|
630
PUT
DexCom
DXCM
$27.6B
| $25.7M | 0.03% |
319,700
-57,900
| -15% | -$4.9M |
|
631
Omnicom Group
OMC
$22.7B
| $25.7M | 0.03% |
406,784
+19,280
| +5% | +$1.31M |
|
632
Corning
GLW
$126B
| $25.6M | 0.03% |
883,572
+349,058
| +65% | +$11.8M |
|
|
HZNP
633
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $25.6M | 0.03% |
414,178
+390,368
| +1,640% | +$27.3M |
|
634
JB Hunt Transport Services
JBHT
$27.1B
| $25.5M | 0.03% |
162,929
+52,237
| +47% | +$9.12M |
|
635
Under Armour Class C
UA
$2.92B
| $25.5M | 0.03% |
4,272,901
+2,693,696
| +171% | +$21.1M |
|
636
Sprouts Farmers Market
SFM
$7.04B
| $25.4M | 0.03% |
916,087
-206,848
| -18% | -$5.88M |
|
637
NCR Voyix
VYX
$1.06B
| $25.4M | 0.03% |
2,176,919
-552,182
| -20% | -$10.1M |
|
|
638
CALL
DexCom
DXCM
$27.6B
| $25.2M | 0.03% |
313,000
+42,200
| +16% | +$3.57M |
|
639
CALL
Caterpillar
CAT
$409B
| $25.2M | 0.03% |
153,400
-66,400
| -30% | -$12.1M |
|
640
Brookfield
BN
$102B
| $25M | 0.03% |
1,136,742
+228,232
| +25% | +$5.91M |
|
641
Eaton
ETN
$157B
| $25M | 0.03% |
187,169
+175,223
| +1,467% | +$24.5M |
|
642
Kinder Morgan
KMI
$73.1B
| $25M | 0.03% |
1,499,966
+253,462
| +20% | +$4.51M |
|
643
PUT
Dick's Sporting Goods
DKS
$18.4B
| $24.9M | 0.03% |
237,600
| – | – |
|
644
PUT
Thermo Fisher Scientific
TMO
$211B
| $24.9M | 0.03% |
49,000
-5,000
| -9% | -$2.8M |
|
645
PUT
NIO
NIO
$11.3B
| $24.8M | 0.03% |
1,573,800
+803,400
| +104% | +$15.9M |
|
646
Fastly Inc
FSLY
$3.17B
| $24.8M | 0.03% |
2,708,597
-127,774
| -5% | -$1.36M |
|
|
CMA
647
DELISTED
Comerica
CMA
| $24.8M | 0.03% |
348,189
+132,393
| +61% | +$10.4M |
|
648
Exelixis
EXEL
$13.9B
| $24.6M | 0.03% |
1,571,452
-206,979
| -12% | -$4M |
|
649
Vermilion Energy
VET
$1.73B
| $24.6M | 0.03% |
1,152,134
-239,200
| -17% | -$5.62M |
|
650
Allegion
ALLE
$13B
| $24.6M | 0.03% |
274,588
-21,318
| -7% | -$2.11M |
|
Similar funds
D.E. Shaw & Co's Q3 2022 Portfolio in Review
As of Q3 2022, D.E. Shaw & Co held 5,820 positions worth $83.7B, down 1.8% from $85.3B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.
D.E. Shaw & Co withdrew a net $3.66B in Q3 2022, closing 679 positions and reducing 1,597 holdings. Its most notable exit was iShares MSCI Emerging Markets ETF, an estimated $171M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Prologis worth $66.1M.
- D.E. Shaw & Co's largest Q3 2022 buy was Prologis: 650,725 shares worth $66.1M.
- D.E. Shaw & Co added most to Visa in Q3 2022, an estimated $365M increase.
- D.E. Shaw & Co's biggest Q3 2022 reduction was PayPal, cutting an estimated $520M.
- D.E. Shaw & Co fully exited iShares MSCI Emerging Markets ETF in Q3 2022, selling an estimated $171M.
- D.E. Shaw & Co's ten largest holdings make up 8.7% of its $83.7B portfolio in Q3 2022.
- D.E. Shaw & Co opened 545 new positions and closed 679 in Q3 2022.
- D.E. Shaw & Co's portfolio value fell 1.8% quarter-over-quarter to $83.7B.
Based on D.E. Shaw & Co's 13F filing for Q3 2022, filed 14 Nov 2022.